Retrospective Cohort Study
Copyright ©The Author(s) 2016.
World J Gastroenterol. May 14, 2016; 22(18): 4547-4558
Published online May 14, 2016. doi: 10.3748/wjg.v22.i18.4547
Table 5 Factors associated with survival according to multivariate analysis in patients undergoing liver retransplantation for hepatitis C virus recurrence, adjusted for center effect and fibrosing cholestatic hepatitis occurrence
Risk factorHazard ratio95%CIP value
Undetectable HCV viremia pre-reLT8.801.96-39.390.004
Receipt of antiviral treatment after reLT4.982.23-11.15< 0.0001
ReLT donor age < 60 yr3.541.42-8.820.007
Non-genotype 13.941.35-11.570.010
Reinscription MELD ≤ 252.451.23-4.880.010

  • Citation: Song ATW, Sobesky R, Vinaixa C, Dumortier J, Radenne S, Durand F, Calmus Y, Rousseau G, Latournerie M, Feray C, Delvart V, Roche B, Haim-Boukobza S, Roque-Afonso AM, Castaing D, Abdala E, D’Albuquerque LAC, Duclos-Vallée JC, Berenguer M, Samuel D. Predictive factors for survival and score application in liver retransplantation for hepatitis C recurrence. World J Gastroenterol 2016; 22(18): 4547-4558
  • URL: https://www.wjgnet.com/1007-9327/full/v22/i18/4547.htm
  • DOI: https://dx.doi.org/10.3748/wjg.v22.i18.4547